CS logo
small CS logo
Centrum Medyczne Dietla 19 Sp. Z O.O.

Krakow, Poland
Medical center in Kraków
Józefa Dietla 19/3, 31-070 Kraków

About Centrum Medyczne Dietla 19 Sp. Z O.O.


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
4
Total Rows: 1

Clinical Trials at Centrum Medyczne Dietla 19 Sp. Z O.O.


During the past decade, Centrum Medyczne Dietla 19 Sp. Z O.O. conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years110033000000Started TrialsCompleted Trails20192020202101234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)
2019-02-19
2022-01-18
Completed
671
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion
2021-03-02
2023-06-15
Active, not recruiting
553
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion
2021-03-02
2023-07-13
Active, not recruiting
729
A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration
2021-04-19
2024-08-09
Active, not recruiting
1,036

Rows per page:

1–4 of 4

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Centrum Medyczne Dietla 19 Sp. Z O.O." #1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 4Hoffmann-La Roche: 4

Created with Highcharts 11.1.0Top CollaboratorsChugai Pharmaceutical: 2Chugai Pharmaceutical: 2

Clinical Trials Conditions at Centrum Medyczne Dietla 19 Sp. Z O.O.


According to Clinical.Site data, the most researched conditions in "Centrum Medyczne Dietla 19 Sp. Z O.O." are "Macular Edema" (2 trials), "Branch Retinal Vein Occlusion" (1 trials), "Central Retinal Vein Occlusion" (1 trials), "Hemiretinal Vein Occlusion" (1 trials) and "Neovascular Age-related Macular Degeneration" (1 trials). Many other conditions were trialed in "Centrum Medyczne Dietla 19 Sp. Z O.O." in a lesser frequency.

Clinical Trials Intervention Types at Centrum Medyczne Dietla 19 Sp. Z O.O.


Most popular intervention types in "Centrum Medyczne Dietla 19 Sp. Z O.O." are "Drug" (4 trials), "Procedure" (3 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Faricimab" (4 trials), "Sham Procedure" (4 trials) and "Aflibercept" (3 trials). Other intervention names were less common.

Clinical Trials Genders at Centrum Medyczne Dietla 19 Sp. Z O.O.


The vast majority of trials in "Centrum Medyczne Dietla 19 Sp. Z O.O." are 4 trials for "All" genders.

Clinical Trials Status at Centrum Medyczne Dietla 19 Sp. Z O.O.


Currently, there are NaN active trials in "Centrum Medyczne Dietla 19 Sp. Z O.O.". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Centrum Medyczne Dietla 19 Sp. Z O.O., undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Centrum Medyczne Dietla 19 Sp. Z O.O., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 4Phase 3: 4

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 3Active, not recruiting: 3Completed: 1Completed: 1